A simple prognostic score to predict recurrence after pancreaticoduodenectomy for ampullary carcinoma: results from the French prospective FFCD-AC cohort.

Fiche publication

Date publication

novembre 2024

Journal

ESMO open

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier , Pr MANFREDI Sylvain

Tous les auteurs :
Roth G, Pellat A, Piessen G, le Malicot K, Schwarz L, Gallois C, Tougeron D, Hautefeuille V, Jary M, Benoist S, Amil M, Desgrippes R, Muller M, Lecomte T, Guillet M, Locher C, Genet C, Manfredi S, Bouché O, Taieb J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39561623

Résumé

Ampullary carcinoma (AC) is a rare and severe gastrointestinal cancer with a disease recurrence rate of around 40% after curative-intent surgery and for which the main prognostic factors and adjuvant treatment decision remain a matter of debate.